Equities Analysts Set Expectations for STERIS’’s Q2 2022 Earnings (TSE:STE)

STERIS’ (TSE:STEGet Rating) – Investment analysts at Stifel Firstegy boosted their Q2 2022 earnings per share (EPS) estimates for STERIS’ in a note issued to investors on Monday, June 20th. Stifel Firstegy analyst C. Pereira now expects that the company will post earnings of $0.17 per share for the quarter, up from their previous estimate of $0.01. Stifel Firstegy also issued estimates for STERIS’’s Q4 2022 earnings at $0.17 EPS, FY2022 earnings at $0.70 EPS and FY2023 earnings at $1.10 EPS.

STERIS’ (TSE:STEGet Rating) last announced its quarterly earnings results on Wednesday, May 11th. The company reported C$0.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.07 by C$0.06. The business had revenue of C$219.54 million for the quarter, compared to the consensus estimate of C$211.03 million.

STERIS’ Company Profile (Get Rating)

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.

Featured Articles

Earnings History and Estimates for STERIS’ (TSE:STE)

Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.